Table 3.
Model 4 | Model 1 | Model 2 | Model 3 | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Training set | Validation set | Training set | Validation set | Training set | Validation set | Training set | Validation set | |||||||||
Low N = 85 | High N = 77 | Low N = 34 | High N = 35 | Low N = 83 | High N = 79 | Low N = 39 | High N = 30 | Low N = 96 | High N = 66 | Low N = 40 | High N = 29 | Low N = 91 | High N = 71 | Low N = 32 | High N = 37 | |
Accuracy | 88.3 | 88.4 | 85.8 | 84.1 | 86.4 | 82.6 | 84.6 | 82.6 | ||||||||
Sensitivity | 85.4 | 88.6 | 84.2 | 77.1 | 76.8 | 74.3 | 78.0 | 85.7 | ||||||||
Specificity | 91.2 | 88.2 | 87.5 | 91.2 | 96.2 | 91.2 | 91.2 | 79.4 | ||||||||
AUC | 0.925 | 0.897 | 0.894 | 0.866 | 0.909 | 0.892 | 0.914 | 0.892 |
AUC, area under the receiver operating characteristic curve; Model 4, Clinic + CTU + CTA + CTV; Model 1, Clinic + CTU; Model 2, Clinic + CTA; Model 3, Clinic + CTV; CTU, CT value of unenhanced; CTA, CT value of arterial phase; CTV, CT value of venous phase.